{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T01:52:04Z","timestamp":1773021124894,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001674","name":"Fondation Leducq","doi-asserted-by":"publisher","award":["DSRR_P34404"],"award-info":[{"award-number":["DSRR_P34404"]}],"id":[{"id":"10.13039\/501100001674","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004200","name":"Stiftelsen Olle Engkvist Byggm\u00e4stare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004200","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["HEALTHF2-2009-241778"],"award-info":[{"award-number":["HEALTHF2-2009-241778"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006310","name":"Medicinska Forskningsr\u00e5det","doi-asserted-by":"publisher","award":["VR2012-3500"],"award-info":[{"award-number":["VR2012-3500"]}],"id":[{"id":"10.13039\/501100006310","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007435","name":"\u00c5ke Wiberg Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007435","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.neuropharm.2015.09.017","type":"journal-article","created":{"date-parts":[[2015,9,15]],"date-time":"2015-09-15T12:39:21Z","timestamp":1442320761000},"page":"13-23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["GSK3\u03b2 inhibition protects the immature brain from hypoxic-ischaemic insult via reduced STAT3 signalling"],"prefix":"10.1016","volume":"101","author":[{"given":"Barbara","family":"D'Angelo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Joakim Ek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanyan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changlian","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mats","family":"Sandberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8953-919X","authenticated-orcid":false,"given":"Carina","family":"Mallard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2015.09.017_bib1","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.pneurobio.2006.07.006","article-title":"The paradoxical pro- and anti-apoptotic actions of GSK3 in the intrinsic and extrinsic apoptosis signaling pathways","volume":"79","author":"Beurel","year":"2006","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2015.09.017_bib2","doi-asserted-by":"crossref","first-page":"21934","DOI":"10.1074\/jbc.M802481200","article-title":"Differential regulation of STAT family members by glycogen synthase kinase-3","volume":"283","author":"Beurel","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2015.09.017_bib3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1742-2094-6-9","article-title":"Lipopolysaccharide-induced interleukin-6 production is controlled by glycogen synthase kinase-3 and STAT3 in the brain","volume":"6","author":"Beurel","year":"2009","journal-title":"J.\u00a0Neuroinflam."},{"key":"10.1016\/j.neuropharm.2015.09.017_bib4","doi-asserted-by":"crossref","first-page":"10191","DOI":"10.1074\/jbc.M007807200","article-title":"Synergistic activation of caspase-3 by m-calpain after neonatal hypoxia-ischemia: a mechanism of \u201cpathological apoptosis\u201d?","volume":"276","author":"Blomgren","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2015.09.017_bib5","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1089\/jir.2005.25.733","article-title":"Stats: multifaceted regulators of transcription","volume":"25","author":"Brierley","year":"2005","journal-title":"J.\u00a0Interferon Cytokine Res."},{"key":"10.1016\/j.neuropharm.2015.09.017_bib6","doi-asserted-by":"crossref","first-page":"4665","DOI":"10.1210\/en.2005-0389","article-title":"Growth hormone-releasing peptide hexarelin reduces neonatal brain injury and alters Akt\/glycogen synthase kinase-3beta phosphorylation","volume":"146","author":"Brywe","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.neuropharm.2015.09.017_bib7","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1111\/j.1460-9568.2005.03982.x","article-title":"IGF-I neuroprotection in the immature brain after hypoxia-ischemia, involvement of Akt and GSK3beta?","volume":"21","author":"Brywe","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2015.09.017_bib8","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/nrn1665","article-title":"WNTs in the vertebrate nervous system: from patterning to neuronal connectivity","volume":"6","author":"Ciani","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2015.09.017_bib9","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S1074-5521(00)00025-9","article-title":"Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription","volume":"7","author":"Coghlan","year":"2000","journal-title":"Chem. Biol."},{"key":"10.1016\/j.neuropharm.2015.09.017_bib10","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000347161","article-title":"Time-dependent effects of systemic lipopolysaccharide injection on regulators of antioxidant defence Nrf2 and PGC-1alpha in the neonatal rat brain","volume":"20","author":"Correa","year":"2013","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.neuropharm.2015.09.017_bib11","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3233\/JAD-2012-120805","article-title":"Treatment of Alzheimer's disease with the GSK-3 inhibitor tideglusib: a pilot study","volume":"33","author":"del Ser","year":"2013","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neuropharm.2015.09.017_bib12","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/jcbfm.2014.255","article-title":"Brain barrier properties and cerebral blood flow in neonatal mice exposed to cerebral hypoxia-ischemia","volume":"35","author":"Ek","year":"2015","journal-title":"J.\u00a0Cereb. Blood Flow Metabolism"},{"key":"10.1016\/j.neuropharm.2015.09.017_bib14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1053\/siny.1999.0114","article-title":"Antenatal brain injury: aetiology and possibilities of prevention","volume":"5","author":"Hagberg","year":"2000","journal-title":"Semin. Neonatol."},{"key":"10.1016\/j.neuropharm.2015.09.017_bib15","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S1474-4422(13)70261-8","article-title":"Mitochondria: hub of injury responses in the developing brain","volume":"13","author":"Hagberg","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuropharm.2015.09.017_bib16","doi-asserted-by":"crossref","first-page":"5910","DOI":"10.1523\/JNEUROSCI.22-14-05910.2002","article-title":"Interleukin-18 involvement in hypoxic-ischemic brain injury","volume":"22","author":"Hedtjarn","year":"2002","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.09.017_bib17","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1073\/pnas.93.7.2719","article-title":"Regulation of mitochondrial pyruvate dehydrogenase activity by tau protein kinase I\/glycogen synthase kinase 3beta in brain","volume":"93","author":"Hoshi","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2015.09.017_bib46","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/nrn2870","article-title":"GSK3 signalling in neural development","volume":"11","author":"Hur","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2015.09.017_bib18","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/(SICI)1098-1136(200005)30:3<253::AID-GLIA5>3.0.CO;2-O","article-title":"Activation of the JAK\/STAT pathway following transient focal cerebral ischemia: signaling through Jak1 and Stat3 in astrocytes","volume":"30","author":"Justicia","year":"2000","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2015.09.017_bib19","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.yjmcc.2005.09.009","article-title":"Glycogen synthase kinase-3beta\/beta-catenin promotes angiogenic and anti-apoptotic signaling through the induction of VEGF, Bcl-2 and survivin expression in rat ischemic preconditioned myocardium","volume":"40","author":"Kaga","year":"2006","journal-title":"J.\u00a0Mol. Cell Cardiol."},{"key":"10.1016\/j.neuropharm.2015.09.017_bib45","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/nn.2408","article-title":"GSK-3 is a master regulator of neural progenitor homeostasis","volume":"12","author":"Kim","year":"2009","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2015.09.017_bib20","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF03033861","article-title":"Unregulated mitochondrial GSK3beta activity results in NADH: ubiquinone oxidoreductase deficiency","volume":"14","author":"King","year":"2008","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.neuropharm.2015.09.017_bib21","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1089\/ars.2013.5455","article-title":"Phosphoinositide 3-kinases upregulate system xc(-) via eukaryotic initiation factor 2alpha and activating transcription factor 4-A pathway active in glioblastomas and epilepsy","volume":"20","author":"Lewerenz","year":"2014","journal-title":"Antioxid. Redox Signal"},{"key":"10.1016\/j.neuropharm.2015.09.017_bib22","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1038\/cddis.2010.33","article-title":"Lithium reduces apoptosis and autophagy after neonatal hypoxia-ischemia","volume":"1","author":"Li","year":"2010","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.neuropharm.2015.09.017_bib23","doi-asserted-by":"crossref","first-page":"9993","DOI":"10.1523\/JNEUROSCI.2057-04.2004","article-title":"Glycogen synthase kinase-3beta phosphorylates Bax and promotes its mitochondrial localization during neuronal apoptosis","volume":"24","author":"Linseman","year":"2004","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.09.017_bib24","first-page":"001","article-title":"The role of glycogen synthase kinase 3 beta in neuroinflammation and pain","volume":"1","author":"Maixner","year":"2013","journal-title":"J.\u00a0Pharm. Pharmacol. Los Angel"},{"key":"10.1016\/j.neuropharm.2015.09.017_bib25","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/ni1221","article-title":"Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3","volume":"6","author":"Martin","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.neuropharm.2015.09.017_bib26","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0165-3806(02)00636-3","article-title":"Effects of interleukin-10 on neonatal excitotoxic brain lesions in mice","volume":"141","author":"Mesples","year":"2003","journal-title":"Brain Res. Dev. Brain Res."},{"key":"10.1016\/j.neuropharm.2015.09.017_bib27","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/sj.jcbfm.9600342","article-title":"Gender-specific neuroprotection by 2-iminobiotin after hypoxia-ischemia in the neonatal rat via a nitric oxide independent pathway","volume":"27","author":"Nijboer","year":"2007","journal-title":"J.\u00a0Cereb. Blood Flow. Metab."},{"key":"10.1016\/j.neuropharm.2015.09.017_bib28","doi-asserted-by":"crossref","first-page":"14226","DOI":"10.1074\/jbc.M111.308841","article-title":"Protein kinase C delta (PKCdelta)-extracellular signal-regulated kinase 1\/2 (ERK1\/2) signaling cascade regulates glycogen synthase kinase-3 (GSK-3) inhibition-mediated interleukin-10 (IL-10) expression in lipopolysaccharide (LPS)-induced endotoxemia","volume":"287","author":"Noh","year":"2012","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2015.09.017_bib29","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/ana.22419","article-title":"Neuronal cell death in neonatal hypoxia-ischemia","volume":"69","author":"Northington","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2015.09.017_bib30","doi-asserted-by":"crossref","first-page":"e8911","DOI":"10.1371\/journal.pone.0008911","article-title":"Light and electron microscopy study of glycogen synthase kinase-3beta in the mouse brain","volume":"5","author":"Perez-Costas","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2015.09.017_bib31","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.1128\/MCB.00180-12","article-title":"Structural and functional characterization of Nrf2 degradation by the glycogen synthase kinase 3\/beta-TrCP axis","volume":"32","author":"Rada","year":"2012","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.neuropharm.2015.09.017_bib32","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.mcn.2008.06.007","article-title":"Functional interference between glycogen synthase kinase-3 beta and the transcription factor Nrf2 in protection against kainate-induced hippocampal cell death","volume":"39","author":"Rojo","year":"2008","journal-title":"Mol. Cell Neurosci."},{"key":"10.1016\/j.neuropharm.2015.09.017_bib33","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1471-4159.2007.05124.x","article-title":"GSK-3beta down-regulates the transcription factor Nrf2 after oxidant damage: relevance to exposure of neuronal cells to oxidative stress","volume":"105","author":"Rojo","year":"2008","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2015.09.017_bib34","doi-asserted-by":"crossref","first-page":"14841","DOI":"10.1074\/jbc.M513737200","article-title":"Glycogen synthase kinase-3beta inhibits the xenobiotic and antioxidant cell response by direct phosphorylation and nuclear exclusion of the transcription factor Nrf2","volume":"281","author":"Salazar","year":"2006","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2015.09.017_bib35","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1159\/000348432","article-title":"Temporal expression of cytokines and signal transducer and activator of transcription factor 3 activation after neonatal hypoxia\/ischemia in mice","volume":"35","author":"Shrivastava","year":"2013","journal-title":"Dev. Neurosci."},{"key":"10.1016\/j.neuropharm.2015.09.017_bib36","doi-asserted-by":"crossref","first-page":"19936","DOI":"10.1074\/jbc.M309304200","volume":"279","author":"Sriram","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2015.09.017_bib37","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1523\/JNEUROSCI.4391-06.2007","article-title":"Matrix metalloproteinase-9 gene knock-out protects the immature brain after cerebral hypoxia-ischemia","volume":"27","author":"Svedin","year":"2007","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.09.017_bib38","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/j.1471-4159.2011.07171.x","article-title":"Glycogen synthase kinase-3 inhibition reduces ischemic cerebral damage, restores impaired mitochondrial biogenesis and prevents ROS production","volume":"116","author":"Valerio","year":"2011","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2015.09.017_bib39","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1742-2094-7-99","article-title":"Glycogen synthase kinase-3beta inactivation inhibits tumor necrosis factor-alpha production in microglia by modulating nuclear factor kappaB and MLK3\/JNK signaling cascades","volume":"7","author":"Wang","year":"2010","journal-title":"J.\u00a0Neuroinflamm."},{"key":"10.1016\/j.neuropharm.2015.09.017_bib40","doi-asserted-by":"crossref","first-page":"48872","DOI":"10.1074\/jbc.M305870200","article-title":"Glycogen synthase kinase-3beta (GSK3beta) binds to and promotes the actions of p53","volume":"278","author":"Watcharasit","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2015.09.017_bib41","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1002\/j.1460-2075.1990.tb07419.x","article-title":"Molecular cloning and expression of glycogen synthase kinase-3\/factor A","volume":"9","author":"Woodgett","year":"1990","journal-title":"EMBO J."},{"key":"10.1016\/j.neuropharm.2015.09.017_bib42","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.neuroscience.2012.04.052","article-title":"Involvement of the Akt\/GSK-3beta\/CRMP-2 pathway in axonal injury after hypoxic-ischemic brain damage in neonatal rat","volume":"216","author":"Xiong","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2015.09.017_bib43","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.cellsig.2008.10.014","article-title":"Glycogen synthase kinase-3 regulates microglial migration, inflammation, and inflammation-induced neurotoxicity","volume":"21","author":"Yuskaitis","year":"2009","journal-title":"Cell Signal"},{"key":"10.1016\/j.neuropharm.2015.09.017_bib44","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/27208","article-title":"Destabilization of beta-catenin by mutations in presenilin-1 potentiates neuronal apoptosis","volume":"395","author":"Zhang","year":"1998","journal-title":"Nature"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839081530109X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839081530109X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T23:56:26Z","timestamp":1762214186000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002839081530109X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":45,"alternative-id":["S002839081530109X"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2015.09.017","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GSK3\u03b2 inhibition protects the immature brain from hypoxic-ischaemic insult via reduced STAT3 signalling","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2015.09.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}